Epirubicin

FDA Approved: * September 15, 2006
Pharm Company: * MAYNE PHARMA USA
Category: Cancer

Epirubicin is an anthracycline drug used for chemotherapy. It can be used in combination with other medications to treat breast cancer in patients who have had surgery to remove the tumor. It is marketed by Pfizer under the trade name Ellence in the US and Pharmorubicin or Epirubicin Ebewe elsewhere. Similarly to other anthracyclines, epirubicin acts by intercalating DNA strands. Intercalation results in complex formation which inhibits DNA and RNA synthesis. It also triggers DNA cleavage by... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Epirubicin Hydrochloride 2 mg/ml Intravenous Injection
NDC: 0115-1675
Labeler:
Impax Generics
Epirubicin Hydrochloride 2 mg/ml Intravenous Injection
NDC: 0143-9202
Labeler:
West-ward Pharmaceuticals Corp
Epirubicin Hydrochloride 2 mg/ml Intravenous Injection
NDC: 0143-9203
Labeler:
West-ward Pharmaceuticals Corp
Epirubicin Hydrochloride 50 mg/25ml Intravenous Injection, Solution
NDC: 0703-3067
Labeler:
Teva Parenteral Medicines, Inc.
Epirubicin Hydrochloride 200 mg/100ml Intravenous Injection, Solution
NDC: 0703-3069
Labeler:
Teva Parenteral Medicines, Inc.
Epirubicin Hydrochloride 2 mg/ml Intravenous Injection
NDC: 25021-203
Labeler:
Sagent Pharmaceutical
Epirubicin Hydrochloride 2 mg/ml Intravenous Injection
NDC: 45963-608
Labeler:
Actavis Pharma, Inc.
Epirubicin Hydrochloride 2 mg/ml Intravenous Injection
NDC: 53104-0211
Labeler:
Cipla Limited
Epirubicin Hydrochloride 200 mg/100ml Intravenous Injection
NDC: 53150-247
Labeler:
Amneal-agila, LLC
Epirubicin Hydrochloride 50 mg/25ml Intravenous Injection
NDC: 53150-250
Labeler:
Amneal-agila, LLC
More Results

Related Brands

Drugs with the same active ingredients